Reproducibility of serum insulin and glucose infusion rate profiles of insulin glargine compared with NPH insulin and insulin ultralente

被引:0
|
作者
Scholtz, HE
Becker, RHA
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A481 / A481
页数:1
相关论文
共 50 条
  • [31] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
    Heise, T
    Nosek, L
    Draeger, E
    Ronn, BB
    Kapitza, C
    Heinemann, L
    DIABETOLOGIA, 2003, 46 : A6 - A7
  • [32] Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes
    Ashwell, Simon G.
    Bradley, Clare
    Stephens, James W.
    Witthaus, Elke
    Home, Philip D.
    DIABETES CARE, 2008, 31 (06) : 1112 - 1117
  • [33] ABSORPTION KINETICS OF NPH INSULIN - I-125 DISAPPEARANCE RATES COMPARED WITH INSULIN PROFILES DURING GLUCOSE CLAMPING
    JACOBS, MAJM
    OOLBEKKINK, M
    VANDERSTAP, H
    DEHOLLANDER, W
    HEINE, RJ
    DIABETOLOGIA, 1992, 35 : A194 - A194
  • [34] NPH Insulin Versus Insulin Glargine Versus NPH Insulin Plus Insulin Glargine for the Treatment of Dexamethasone-Induced Hyperglycemia in Patients With COVID-19: A Retrospective Cohort Study
    Fornwald, Courtney R. R.
    Tuttle, Natalie S. S.
    Murphy, Julie A. A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (02) : 68 - 74
  • [35] A comparison between humulin ultralente and humulin NPH insulin in insulin requiring type 2 diabetes
    Meneghini, LF
    Goldberg, RB
    Sosenko, JM
    DIABETES, 1999, 48 : A439 - A439
  • [36] Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long-acting insulin in Type 2 diabetes
    Parkner, T.
    Laursen, T.
    Vestergaard, E. T.
    Hartvig, H.
    Smedegaard, J. S.
    Lauritzen, T.
    Christiansen, J. S.
    DIABETIC MEDICINE, 2008, 25 (05) : 585 - 591
  • [37] The use of basal insulin infusion in a glucose clamp alters the late glucodynamic profile of NPH insulin
    Soon, DKW
    Yeo, KP
    Chan, C
    de la Pena, A
    Ernest, CS
    Lim, M
    Wise, SD
    DIABETOLOGIA, 2004, 47 : A272 - A273
  • [38] Comparison of insulin lispro mixed with NPH or ultralente insulin twice daily in type 1 patients
    Reviriego, J
    Bolanos, E
    DIABETES, 1998, 47 : A103 - A103
  • [39] Risk of diabetic foot ulceration during treatment with insulin glargine and NPH insulin
    Kostev, K.
    Dippel, F. W.
    Rockel, T.
    Siegmund, T.
    JOURNAL OF WOUND CARE, 2012, 21 (10) : 483 - 488
  • [40] Progression of retinopathy with insulin glargine or NPH insulin - A multi-trial analysis
    Forjanic-Klapproth, J
    Home, PD
    DIABETOLOGIA, 2001, 44 : A287 - A287